<DOC>
	<DOCNO>NCT02143440</DOCNO>
	<brief_summary>To investigate daily dose insulin newly diagnose Chinese type 2 diabetic patient use continuous subcutaneous insulin infusion ( CSII ) initial therapy .</brief_summary>
	<brief_title>The Initial Assessment Daily Insulin Dose Newly Diagnosed Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>All participant type 2 diabetes , diagnose World Health Organization criterion , recruit outpatient Endocrinology Department Shanghai Renji Hospital . Patients history coronary heart disease , abnormal renal function , active liver disease , chronic metabolic acidosis ( include diabetic ketoacidosis ) , severe chronic gastrointestinal disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>